Acadia Healthcare (NASDAQ:ACHC) Upgraded at StockNews.com

StockNews.com upgraded shares of Acadia Healthcare (NASDAQ:ACHCFree Report) from a sell rating to a hold rating in a report issued on Monday morning.

A number of other analysts have also recently weighed in on the company. Barclays lowered their price objective on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their target price on Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Friday, September 20th. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Finally, KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $86.67.

View Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Trading Down 0.0 %

Shares of NASDAQ ACHC opened at $42.49 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business’s 50 day moving average price is $64.29 and its 200-day moving average price is $67.36. Acadia Healthcare has a fifty-two week low of $41.42 and a fifty-two week high of $87.77. The company has a market cap of $3.95 billion, a price-to-earnings ratio of 13.93, a PEG ratio of 1.33 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. On average, sell-side analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in ACHC. Point72 Asset Management L.P. raised its holdings in shares of Acadia Healthcare by 266.0% during the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after acquiring an additional 1,650,040 shares during the period. Millennium Management LLC raised its holdings in shares of Acadia Healthcare by 3,067.8% during the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after acquiring an additional 1,055,894 shares during the period. William Blair Investment Management LLC raised its holdings in shares of Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares during the period. Vaughan Nelson Investment Management L.P. raised its holdings in shares of Acadia Healthcare by 67.9% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock worth $49,541,000 after acquiring an additional 296,625 shares during the period. Finally, Clearline Capital LP purchased a new position in shares of Acadia Healthcare during the 2nd quarter worth $11,179,000.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Read More

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.